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Strains of the Propionibacterium 
acnes type III lineage are associated 
with the skin condition progressive 
macular hypomelanosis
Emma Barnard1,2, Jared Liu2, Eliza Yankova3, Silvana M. Cavalcanti4, Marcelo Magalhães5, 
Huiying Li2,6, Sheila Patrick1 & Andrew McDowell1,3
Progressive macular hypomelanosis (PMH) is a common skin disorder that causes hypopigmentation 
in a variety of skin types. Although the underlying aetiology of this condition is unclear, there is 
circumstantial evidence that links the skin bacterium Propionibacterium acnes to the condition. We 
now describe the first detailed population genetic analysis of P. acnes isolates recovered from paired 
lesional and non-lesional skin of PMH patients. Our results demonstrate a strong statistical association 
between strains from the type III phylogenetic lineage and PMH lesions (P = 0.0019), but not those 
representing other phylogroups, including those associated with acne (type IA1). We also demonstrate, 
based on in silico 16S rDNA analysis, that PMH isolates previously recovered from patients in Europe 
are also consistent with the type III lineage. Using comparative genome analysis, we identified multiple 
genomic regions that are specific for, or absent from, type III strains compared to other phylogroups. In 
the former case, these include open reading frames with putative functions in metabolism, transport 
and transcriptional regulation, as well as predicted proteins of unknown function. Further study of these 
genomic elements, along with transcriptional and functional analyses, may help to explain why type III 
strains are associated with PMH.
The common and worldwide skin disorder progressive macular hypomelanosis (PMH) is characterised by asymp-
tomatic, non-scaly hypochromic macules found mainly on the front and back of the trunk, and is often mis-
taken for pityriasis versicolor and pityriasis alba; the condition rarely affects the face. While PMH can affect both 
sexes, it is much more common in young females and can spontaneously disappear after mid-life. Histologically, 
PMH lesions have a normal looking dermis but diminished pigment in the epidermis, with small aggregated and 
membrane-bound melanosomes replacing the large melanosomes found in normal skin1. While the underlying 
cause of this condition remains unclear, there is growing evidence to suggest that the Gram-positive anaerobic 
skin bacterium Propionibacterium acnes may play an important role in the aetiology of the condition2–4. In par-
ticular, P. acnes is frequently cultivated from lesional biopsies and has been observed in histological sections, but 
recovery from peri-lesional, normal-looking skin is infrequent5. Counts of the bacterium in lesional skin are 
also much higher as measured by quantitative real-time PCR (qPCR)4. Furthermore, analysis of lesions under a 
Wood’s lamp reveals a red follicular fluorescence due to the production of porphyrins by the bacterium, a phe-
nomenon not observed with healthy pigmented skin on the trunk region2,4. Consistent with a role for P. acnes 
in PMH, the administration of topical and oral antibacterials and UVA phototherapy often proves an effective 
treatment leading to repigmentation of the lesions5–8.
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A previous study by Relyveld et al. using a combination of Amplified Fragment Length Polymorphism (AFLP) 
analysis, 16S rDNA sequencing, and biochemical profiling, found that P. acnes isolates cultivated from the PMH 
biopsy tissue of patients in the Netherlands, classified as ‘DNA group 3’, were genetically and phenotypically 
distinct from isolates associated with acne vulgaris3. This provides initial evidence that a specific phylogenetic 
grouping of P. acnes, or possibly a novel Propionibacterium species, is associated with PMH3. To date, however, 
a detailed population genetic analysis of isolates recovered from PMH lesions has been lacking, and it remains 
unclear which, if any, of the now well described phylogroups of P. acnes (types IA1, IA2, IB and IC, II and III) 
may be associated with the condition. Such studies are important since specific lineages of the bacterium with an 
increased potential to cause infection may exist, while others may prove to be associated with health9–13; the latter 
may therefore provide the basis for the development of novel probiotic therapies to treat PMH if disease-causing 
lineages are identified. In this study, we describe the first detailed population genetic analysis of P. acnes strains 
isolated from paired lesional and non-lesional skin of patients with PMH. We also compare the genomes of a 
number of P. acnes type III strains, including those isolated from the skin of PMH patients, with P. acnes strains 
representing all other phylogenetic divisions of the bacterium.
Results
P. acnes type III lineage is significantly associated with PMH. Levels of P. acnes in the lesional skin 
of this study cohort were significantly higher than non-lesional skin samples based on genome copy number 
(P < 0.001 Wilcoxon Signed Rank test; Fig. 1). Consistent with these results, culture-based analysis revealed a 
significant association between the presence of P. acnes in the lesions of 27/34 (79%) patients with PMH versus 
adjacent and paired non-lesional, normal-looking skin samples which mostly showed no evidence of any growth 
(P < 0.0001 McNemar’s test) (OR = 27; 95% CI = 4.45–1105) (Table 1). Of the seven lesional skin samples that 
were classified as culture-negative, four did display some growth of P. acnes but, for stringency in the identifica-
tion of culture-positive samples, they were classified as negative since their genome copy numbers were low and 
below our cut-off value. Multiplex PCR analysis of multiple P. acnes colonies revealed little evidence of mixed 
phylogroups in the lesions based on culture, except in two cases, which is consistent with previously published 
results3 (Table 1). Of the other lesional biopsy samples positive by culture (n = 25), 52% had the type III lineage 
present versus 16% with type IA1, 12% with type IA2, 4% with type IB and 16% with type II (Table 1). Upon Gram 
staining, all PMH isolates identified as type III had the characteristic elongated cellular morphology that we orig-
inally described for this genetic division14 (Supplementary Fig. S1). One patient had growth of P. acnes from adja-
cent non-lesional skin only; in this case, both type III and IA1 strains were recovered (Table 1). The differences in 
the number of type III strains isolated from the PMH lesions versus the paired non-lesional skin was statistically 
significant using the McNemar’s test for paired nominal data, thus demonstrating a striking association between 
this genetic division and PMH (P = 0.0019; OR = 14; 95% CI = 2.13–592). In contrast, no significant difference 
was found between paired lesion and non-lesional skin of the patients for the presence of types IA1, IA2, IB and 
II lineages (P > 0.05).
Figure 1. Boxplot of P. acnes genome copy number for paired non-lesional and lesional skin samples from 
patients with PMH. Centre lines reflect medians and box limits indicate the 25th and 75th percentiles.
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AFLP DNA group 3 strains are also consistent with the P. acnes type III lineage. Relyveld et al. 
previously reported that the AFLP DNA group 3 strains recovered from PMH lesions differed from the 16S rDNA 
gene sequence of the type IA1 strain ATCC6919 (NCTC737) (accession number AB042288.1) by a single nucleo-
tide polymorphism (SNP), G1243A3. Alignment of the 16S rDNA sequences from ATCC6919, KPA171202 (type 
IB), NCTC10390 (type II) and 10 publically available type III isolates confirmed the presence of this specific SNP 
in eight of the type III isolates (80%), while two were identical to ATCC6919, KPA171202 and NCTC10390 at this 
site (Fig. 2). Inspection of the 16S rRNA gene sequences from 97 sequenced P. acnes genomes currently publicly 
available, and covering all other phylogroups (IA1, IA2, IB, IC and II), found no evidence of this SNP outside of the 
type III division. Therefore, this SNP would appear specific to strains from the type III lineage. Further inspection 
of published 16S metagenomic sequence data of P. acnes populations within the skin revealed that the 16S rRNA 
SNP of ribotype (RT) 9, G1268A (Escherichia coli equivalent coordinate; Supplementary Fig. S2)12, corresponds 
to this type III-specific SNP, suggesting that RT9 may belong to type III.
Biochemical analysis of type III isolates from PMH lesions. Analysis of the biochemical phenotype 
of three representative type III strains recovered from PMH lesions using the Rapid ID 32A multi-test iden-
tification system failed to correctly identify the isolates as P. acnes (Supplementary Table S1). In contrast, the 
acne type IA1 isolates ATCC6919 (NCTC737) and hdn-1, representing AFLP DNA group 1, and type II isolates 
NCTC10390 and BR-26, representing AFLP DNA group 2, were correctly identified as P. acnes with an identity of 
99.9% (Supplementary Table S1). With the type III PMH strains tested, the current Rapid ID 32A database incor-
rectly identified them as Clostridium tetani (97.5% highest identity), Eggerthella lenta (65.3% highest identity) or 
Patient ID#
Culture result
Multiplex PCR results from 
multi-isolate analysis
Lesion Non-lesion Lesion Non-lesion
BR-1 + − IA2 − 
BR-2 − − − − 
BR-3 + − IA1 − 
BR-4 + − IA1 − 
BR-5 + − IA2 − 
BR-6 − − − − 
BR-7 + − II − 
BR-8 − − − − 
BR-9 + − III − 
BR-10 + − II − 
BR-11 − − − − 
BR-12 + − IB − 
BR-13 + − III − 
BR-14 + − III − 
BR-15 − − − − 
BR-16 + − III − 
BR-17 + − III − 
BR-18 + − III − 
BR-19 − − − − 
BR-20 − + − III/IA1
BR-21 + − III − 
BR-22 + − III − 
BR-23 + − IA1 − 
BR-24 + − II − 
BR-25 + − IB/II − 
BR-26 + − II − 
BR-27 + − III − 
BR-28 + − IA1 − 
BR-29 + − III − 
BR-30 + − III/IA2 − 
BR-31 + − IA2 − 
BR-32 + − III − 
BR-33 + − III − 
BR-34 + − III − 
Table 1.  Culture and multiplex PCR results for paired lesional and non-lesional skin from patients with 
PMH.
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Fusobacterium nucleatum (42.1% highest identity) species (Supplementary Table S1); members of these species 
are anaerobic bacilli and potentially pathogenic to humans.
Multilocus Sequence Typing (MLST) of isolates from PMH lesional and non-lesional skin. To 
provide a more detailed picture of the population genetic structure of strains recovered from lesional and 
non-lesional skin, we selected a total of 24 isolates pre-screened by multiplex PCR for higher resolution MLST8 
analysis. One strain was from non-lesional skin (type III) and 23 were from PMH lesions, the majority of which 
were type III (n = 15), along with two strains each of types IA1, IA2, IB and II (n = 8). MLST confirmed the 
phylogroup designations obtained by multiplex PCR analysis of the isolates, and further resolved a total of five 
distinct type III genotypes represented by ST75, ST76, ST77 and two new STs. All five STs were recovered from 
lesional sites, while ST76 also represented the type III isolate from non-lesional skin. Lesional isolates of types 
IA1, IA2 and IB phylogroups had very common, globally disseminated genotypes represented by ST1 (type IA1), 
ST2 (type IA2), ST22 (type IA2) and ST5 (type IB), while type II strains were represented by ST69 and a new ST. 
In silico analysis of recently published draft genome sequences of two type III isolates (PMH5 and PMH7) also 
recovered from the lower back of patients with PMH in Aalborg, Denmark (from skin swabs) revealed the geno-
type ST3315. All type III STs identified belonged to the previously described type III clonal complex (CC), CC77 
which has ST77 as the ancestral or founding genotype10,11.
Genomic characteristics of type III strains. To infer whether potential functional differences exist 
between type III and other P. acnes lineages, four publicly available type III genomes (HL201PA1, JCM18909, 
PMH5 and PMH7), including two from PMH lesional skin (PMH5, PMH7), were compared with P. acnes 
genomes from type I (n = 69) and type II (n = 12) lineages, respectively (Fig. 3). Comparative genomic analyses 
revealed the presence of eight non-core regions found exclusively in all four type III genomes (type III-specific 
regions; Fig. 3; Supplementary Table S2), and a further two regions (regions 19 and 22) specific to three of the 
four type III genomes (HL201PA1, PMH5 and PMH7) (Fig. 3; Supplementary Table S2). Additionally, we iden-
tified regions found in type III strains that were also shared by a small number of other P. acnes strains, including 
those from the type IB and IC phylogroups (Supplementary Table S2). Genomic regions primarily found in type 
III strains (with some minor exceptions) accounted for over 109 kb, and contained 111 predicted open reading 
frames (ORFs) with putative functions in metabolism, transport and transcriptional regulation, as well as phage 
proteins and a large number of predicted proteins of unknown function (Supplementary Table S2). Within region 
18, which is exclusive to all four type III genomes, two putative type II secretion system (T2SS) components and 
a putative operon of tight adherence (Tad) genes, consisting of pilus components TadE and CpaB, as well as pre-
pilin peptidase A24, were identified (Supplementary Table S2). However, this region shows no homology with a 
previously described Tad locus that occurs in a plasmid from the type IA2 strain HL096PA113.
Compared to type I and type II strains, type III strains were found to lack a number of genomic regions, with 
a cumulative length of 69.6 kb (type III-absent regions) (Supplementary Table S3). In particular, all four of the 
type III strains lack 17 genomic regions present in other P. acnes type I and type II strains (Fig. 3). Additionally, 
three of the four type III genomes (HL201PA1, PMH5 and PM7) are missing another five genomic regions that 
are present in all other P. acnes phylogroups, as well as type III strain JCM18909 (Fig. 3; Supplementary Table 
S3). A further four regions absent in all type III genomes were also missing from a small number of other P. acnes 
strains, including those from the type IB and IC phylogroups similar to the findings of Tomida et al.16 (Fig. 3; 
Supplementary Table S3). ORFs encoding dimethyl sulfoxide reductase, hyaluronate lyase, class IIb bacterioc-
ins, cobalamin biosynthesis, iron and other ABC transporter systems and maltose metabolism were found to be 
absent in type III strains. Furthermore, all type III strains appear to have an inactive CRISPR/cas system that we 
previously described in this bacterium12,16.
Figure 2. Alignment of the 16S rDNA sequence from ATCC6919 (type IA1), KPA171202 (type IB) and 
NCTC10390 (type II) versus type III isolates. The 16S rDNA G> A SNP described by Relyveld et al.3 as a 
genetic marker of AFLP DNA group 3 strains is highlighted. This SNP was present in eight of the type III 
isolates analysed, but absent in type strains from the other major P. acnes lineages.
www.nature.com/scientificreports/
5Scientific RepoRts | 6:31968 | DOI: 10.1038/srep31968
Discussion
The categorical demonstration in this study that type III strains are strongly associated with PMH raises the 
possibility that this lineage may influence the development of the condition, although this yet remains to be 
established. Our determination that the AFLP DNA group 3 strains previously isolated from PMH patients in the 
Netherlands also appear to belong to the type III lineage, and not a novel Propionibacterium species as suggested3, 
adds additional weight to support this view, as does the recent isolation of type III strains from the lower back 
of two patients with PMH in Aalborg, Denmark15. Furthermore, the observation that type III strains recovered 
from PMH lesions could not be identified as P. acnes using the current Rapid ID 32A multi-test identification 
system, unlike strains of types I and II, is also consistent with the results previously described for AFLP DNA 
group 3 strains isolated from PMH patients3. While the high rate of P. acnes recovery, especially type III, from 
PMH lesions does not in itself prove causality, the circumstantial evidence linking this bacterium to the aetiology 
of the condition is strong, especially the low rate of recovery of P. acnes form peri-lesional skin and the resolution 
of symptoms (repigmentation) with anti-bacterial therapeutics5–8. Other factors are, however, also likely to be 
important in the development of PMH including genetic factors, hormonal influences and the host response to 
the skin microbiota, which may prevent disease in some individuals but not in others.
The association of type III strains with PMH provides evidence that this genetic division may be linked to 
human disease, and not represent ‘true’ commensals solely associated with skin health as tentatively suggested 
previously10,11. The marked presence of type III strains in PMH lesions is remarkable and in stark contrast to the 
P. acnes types isolated from the skin condition acne vulgaris, which appears to be predominately associated with 
epidemic lineages from the type IA1 grouping9–12,17. This may help to explain why no clear correlation exists 
between acne and the development of PMH3. Type III strains are present on normal skin and have been isolated 
from the face and other sites10, but previous 16S rDNA-based metagenomic analysis of facial skin from healthy 
individuals and acne patients in the United States revealed that type III strains are in low abundance in this 
region12. The overwhelming majority of strains identified in this previous acne study belonged to the type I divi-
sion with < 1% of all clones containing the characteristic type III 16S rDNA mutation12. Against this background, 
the rate of detection of type III strains from PMH patients, particularly using a culture-based approach, is strik-
ing. This association between type III strains and PMH is further supported by the isolation of type III strains 
from other PMH cohorts in Europe3,15.
The previous observation of a relatively higher rate of recovery of type III strains from intervertebral disc 
material (excised disc protrusion) removed during spinal surgery is now also interesting in light of our results18. 
Figure 3. Presence and absence of non-core genomic regions across 85 P. acnes genomes. A total of 336 
non-core regions (columns) from 85 P. acnes genomes (rows) are clustered based on similar patterns of presence 
(yellow) and absence (blue) of each region. Size and genomic location of each non-core region are not reflected 
in the plot. The RT and MLST8 data10,12 for each genome are listed after the strain ID. ND - not determined.
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These earlier studies led to the proposal that chronic, low-grade P. acnes infection may play a role in the develop-
ment of severe sciatica18–21. However, this is a controversial idea, and some studies suggest that the presence of the 
bacterium in such material simply reflects contamination of the surgical wound site from the surrounding skin on 
the lower back, even after pre-operative skin antisepsis and antimicrobial prophylaxis22–25. While the abundance 
of type III strains within and between different body sites of individuals currently remains poorly defined, the 
isolation of type III strains from such contaminated material would tentatively suggest that the relative proportion 
of type III colonizing the skin on the lower back, and possibly other regions of the trunk, may be higher with this 
lineage than at other sites which may explain, at least in part, why the trunk is affected by PMH and not the face.
To better understand the nature of the strains associated with PMH we performed high resolution MLST 
on 24 isolates. Although the type III phylogroup is globally disseminated within the human population10,11, our 
analysis revealed that the type III STs recovered from lesional and paired non-lesional skin of the PMH patients 
are distinct from those so far recovered from PMH lesions, facial skin, and other clinical samples in Europe. Some 
of these STs (particularly ST75 and ST77) have, however, been previously described in relation to non-acneic 
and normal skin sampled from subjects in this region of Brazil10,11. In contrast, the PMH isolates recovered from 
patients in Aalborg, Denmark, had the genotype ST33, which has been identified in association with spinal disc 
material removed from patients undergoing spinal surgery in Birmingham, UK10,11,14, as well as from the normal 
facial skin of a subject in Hungary10; this provides tentative evidence for the widespread dissemination of this 
particular type III ST in Europe and possibly further afield. Interestingly, ST77, while currently only described 
in association with Brazilian skin, is the founder genotype for ST33 and ST81 currently identified in Europe10. 
Normally, founding genotypes are more prevalent within the population and widely disseminated. Further epide-
miological studies will, therefore, enable us to investigate how geographically widespread the different type III STs 
identified in this study actually are, and whether they are enriched in the skin microbiota of Brazilian individuals 
versus those in Europe and elsewhere, particularly those with PMH, which would initially appear to be the case. 
In contrast to the type III strains identified in this study, MLST analysis of other lesional isolates revealed STs that 
are common and globally disseminated on the skin of the human population10,11. While the overall recovery of 
such strains from PMH lesions was low compared with type III, and not statistically significant, their overall rate 
of isolation was still higher compared to non-lesional skin; the genome counts of P. acnes in lesional skin from 
such samples were sometimes very high in comparison to the adjacent non-lesional skin. The exact role such phy-
logroups may play in influencing the development of PMH in these particular cases therefore remains unclear. In 
acneic skin, we also see a similar pattern where phylogroups other than type IA1 are isolated, but at significantly 
reduced rates.
The strong association of P. acnes type III strains with PMH may reflect distinct genomic and transcriptomic 
properties of strains from this genetic division which are important in the interaction with the human host. 
Previous phenotypic studies with a limited number of type III strains have found that they can adopt a filamen-
tous morphology, and do not produce cell surface dermatan sulphate-binding adhesins, sialidase or β -haemolytic 
activity, unlike the type IA lineage, but our understanding of their functional potential is still very limited9,11,14,17. 
Although the primary focus of this study was epidemiological, we also conducted a comparative genomic anal-
ysis to investigate whether differences between type III and type I and II strains could provide tentative clues as 
to why this lineage in particular accumulates within PMH lesional skin, but is not associated with acne. Within 
type III strains, an inactive CRISPR/cas system is present which may be relevant to the acquisition of genetic 
loci that contribute to virulence, adaptation and disease association12. In light of this, the observation of the type 
III-specific region 18 containing T2SS genes, more commonly found in Gram-negative bacteria, was interesting. 
Such genes have been linked to a broad range of infections and disease and could provide a mechanism whereby 
secreted proteins promote pathogen colonisation and contribute to host tissue damage26. These T2SS genes are in 
close genomic proximity to a putative Tad locus, a virulence factor in several bacterial pathogens, and together 
may form a potential type III-specific pathogenicity island. This region, however, shows no homology with a 
previously described Tad locus found in acne-associated strains from the type IA1 clade13. Furthermore, two 
genomic islands, known as loci 1 and 2, that contain genes proposed to enhance virulence via increased bacterial 
adhesion and host immune response, and also present in acne-associated strains, are absent from the type III 
strains examined. Other notable differences include the presence of a large number of type III-specific hypothet-
ical proteins of unknown function, and the presence and absence of specific ABC transporter proteins which are 
important in bacterial cell viability and physiology, as well as pathogenicity. A dimethyl sulfoxide reductase gene, 
which may influence growth rate under anaerobic conditions, was also missing from type III strains, as was a pre-
viously described hyaluronate lyase27. We also observed other differences in relation to genes involved in various 
metabolic processes, including sugar utilization. As the skin is an ecosystem of diverse habitats, these differences 
may all be important in relation to specific niche adaptation and colonization of different skin sites. Combined 
with functional differences, this could potentially explain their association with PMH on the truck, but not facial 
acne. Our genomic comparisons also revealed that the Japanese facial isolate JCM1890928 lacked a number of 
genomic regions found in the other three type III genomes, but shared similarities with P. acnes isolates belonging 
to the type I and type II lineages which are abundant on facial skin12. This could indicate that isolates belonging 
to this lineage are equipped with unique metabolic properties to aid adaptation to the niche from where they 
were isolated, but this suggestion is currently tentative due to the assembly of JCM18909 which has a much lower 
N50 than the other genomes. Genome sequencing of more type III and PMH-derived isolates, as well as further 
studies incorporating transcriptional and functional characterisation of type III-specific genomic elements, will 
undoubtedly provide additional insight into the role played by type III strains in PMH.
In conclusion, while the underlying aetiology of PMH is still not firmly established, in this study we have con-
clusively demonstrated a high rate of P. acnes type III in PMH lesional skin using a culture-based method for the 
detection of viable bacteria. In contrast, there was little evidence of P. acnes in adjacent non-lesional skin based 
on plate culture of punch biopsies, which reflected lower levels of the bacterium in these samples as measured by 
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qPCR analysis. This is consistent with the study of McGinley et al.29 who found that the prevalence of P. acnes on 
the lower back of the trunk was significantly reduced when compared with the upper trunk and face where levels 
of sebum production are higher. This appears to suggest enrichment or abnormal overgrowth of the bacterium 
at lesional skin sites on the trunk of patients, although the underlying factor(s) responsible for this is currently 
unclear. Future non-culture-based metagenomic studies will better capture the overall multi-phyletic community 
level structure and functional potential of the skin microbiota in PMH patients, especially alongside healthy 
non-PMH control subjects, and may provide deeper insights into the prevalence and role of type III and other 
phylogroups in the condition.
Materials and Methods
Patients and sampling. The P. acnes isolates analysed in this study were previously recovered from 34 PMH 
patients attending a dermatology outpatient clinic at the Oswalso Cruz University Hospital, Recife, Brazil from 
March-to-May 2008, as originally described by Cavalcanti et al.4. The original study was approved by the Ethics 
Commission at Oswalso Cruz University Hospital (no. 147/2007) and written informed consent was obtained 
from all subjects. Experiments were performed in accordance with relevant approved guidelines and regulations. 
In brief, PMH was characterized by the presence of asymptomatic hypochromic macules on the back with a 
tendency to spread to the middle of the back. The patients were aged between 18 and 42 years with the majority 
being female (75%). Most patients (55%) had no family history of PMH and phototypes IV and V were the most 
common reflecting this region of Brazil. The study exclusion criteria included patients with acne on the back, 
the presence of dermatosis on the truck, lactation, or the use of antimicrobials during the three months prior 
to consultation. All patients were submitted to a dermatological naked eye exam by three dermatologists and 
a Wood’s lamp exam in a darkroom to detect the presence of follicular fluorescence due to bacterial porphyrin 
production. Lesional and non-lesional skin from the back was identified using the Wood’s lamp and naked eye 
examination, and fragments from the same anatomical site removed with a minimum distance of 1 cm using a 4 
mm skin punch.
Quantitative Real Time PCR (qPCR). P. acnes genome copy number in DNA extracted from the macer-
ates of lesional and non-lesional skin was determined in triplicate by qPCR as described previously4.
Bacterial strains and culture. The original lesional and non-lesional skin fragments were homogenized 
and the macerates cultured under anaerobic conditions as previously described4. Multiple colonies of presump-
tive P. acnes were initially identified based on a combination of Gram staining and biochemical analysis (produc-
tion of indole, nitrate and catalase and esculin degradation). All bacterial strains were maintained at − 80 °C in 
brain heart infusion (BHI) broth containing 12% (v/v) glycerol. Prior to molecular analysis, anaerobic isolates 
were cultured on anaerobic horse blood agar plates (Oxoid Ltd., Hampshire, United Kingdom) at 37 °C in an 
anaerobic cabinet (Mark III; Don Whitley Scientific) under an atmosphere of 10% H2, 10% CO2, and 80% N2 for 
a minimum of five days. For stringency in our results, samples were only classified as culture positive if they also 
had a corresponding P. acnes genome copy number that was above the third quartile (Q3) + 3 x interquartile 
range (IQR) value obtained with non-lesional samples that were culture-negative.
Multiplex PCR analysis of isolates. Bacterial genomic DNA was purified using a QIAamp DNA mini kit 
(QIAGEN, United Kingdom) and PCR amplification was carried out using a MultiGene thermocycler (Labnet 
International). Initial typing of multiple P. acnes isolates was performed using a rapid multiplex PCR assay as 
previously described30. This assay confirms P. acnes species identity and phylogeny of isolates (types IA1, IA2, IB 
and IC, II and III) based on primer sets targeting the 16S rRNA gene as well as a series of protein-encoding genes.
MLST. High resolution typing of isolates was carried out using an eight gene scheme (4253 bp) previously 
described for this bacterium (MLST8)10. Sequencing was performed on an ABI PRISM genetic analyser (Life 
Technologies). Allele and sequence types (ST) were compared to those within the P. acnes MLST database at 
http://pubmlst.org/pacnes/.
Bioinformatic analyses. Core and non-core regions of 85 P. acnes genomes were calculated as previously 
described16. Briefly, core regions were calculated by mapping 84 genome sequences against the reference genome 
KPA171202 using Nucmer31. Regions of KPA171202 that aligned with all 84 genomes were identified within the 
84 “.coords” output files, and the corresponding aligned regions in all 85 genomes were extracted. For each set 
of core regions of a genome, 124,731 single nucleotide polymorphisms (SNPs) relative to KPA171202 were iden-
tified and concatenated into a single sequence. MEGA v5 was then used to calculate a neighbour-joining phy-
logenetic tree based on the p-distances between each of the 85 concatenated SNP sequences32. The bootstrap tree 
inferred from 200 replicates was used. To determine non-core regions across the 85 isolates, Nucmer was used 
to align the KPA171202 genome to one of the 84 other genomes in order to determine the regions unique to the 
latter isolate. These regions were then added to the KPA171202 genome to form a second reference sequence that 
was aligned to another of the remaining 83 genomes. Iterating the above process for all the remaining isolates 
resulted in a pan-genome of the 85 isolates. The core regions were subtracted from the pan-genome to obtain 
a set of noncore regions. Protein encoding sequences in non-core regions were predicted by GeneMark.hmm33 
using KPA171202 as a reference. Annotations were performed using BlastX against the NCBI RefSeq protein 
database.
Biochemical analysis. Biochemical analysis was carried out using a RAPID ID 32A biochemical profiling 
kit according to the manufacturer’s instructions (bioMérieux, UK).
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Statistical analysis. Comparison of phylogroups between paired samples was performed using McNemar’s 
test for paired nominal data (two-tailed). Genome copy number between paired samples was compared using the 
non-parametric Wilcoxon Signed Rank test (two-tailed).
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